Fetroja
| Chemical Name | cefiderocol |
| Dosage Form | Injectable (intravenous; 1 g/vial) |
| Drug Class | Antibacterials |
| System | Urinary |
| Company | Shionogi Inc. |
| Approval Year | 2019 |
Indication
- Fetroja is indicated in patients 18 years of age or older who have limited or no alternative treatment options, for the treatment of complicated urinary tract infections (cUTI), including pyelonephritis caused by susceptible Gram-negative microorganisms.